Biogen advances Alzheimer’s tau program despite midphase miss

🌐 Fierce Biotech —
Biogen advances Alzheimer’s tau program despite midphase miss

AI Summary

Biogen is pushing forward with its Alzheimer's tau program despite setbacks in mid-phase trials. This decision could impact the future of Alzheimer's treatment and the company's market performance.

Markets Health Biogen Alzheimer's tau program

Read original source →